57
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CD4 + T Cell Help Impairs CD8 + T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Self-antigens expressed in extrathymic tissues such as the pancreas can be transported to draining lymph nodes and presented in a class I–restricted manner by bone marrow-derived antigen-presenting cells. Such cross-presentation of self-antigens leads to CD8 + T cell tolerance induction via deletion. In this report, we investigate the influence of CD4 + T cell help on this process. Small numbers of autoreactive OVA-specific CD8 + T cells were unable to cause diabetes when adoptively transferred into mice expressing ovalbumin in the pancreatic β cells. Coinjection of OVA-specific CD4 + helper T cells, however, led to diabetes in a large proportion of mice (68%), suggesting that provision of help favored induction of autoimmunity. Analysis of the fate of CD8 + T cells indicated that CD4 + T cell help impaired their deletion. These data indicate that control of such help is critical for the maintenance of CD8 + T cell tolerance induced by cross-presentation.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Determination of lymphocyte division by flow cytometry.

          Techniques currently available for determining cell division are able to show one or, at best, a limited number of cell divisions. Other methods exist which can quantify overall division, but tell nothing about the division history of individual cells. Here we present a new technique in which an intracellular fluorescent label is divided equally between daughter cells upon cell division. The technique is applicable to in vitro cell division, as well as in vivo division of adoptively transferred cells, and can resolve multiple successive generations using flow cytometry. The label is fluorescein derived, allowing monoclonal antibodies conjugated to phycoerythrin or other compatible fluorochromes to be used to immunophenotype the dividing cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help

            Class I–restricted presentation is usually associated with cytoplasmic degradation of cellular proteins and is often considered inaccessible to exogenous antigens. Nonetheless, certain exogenous elements can gain entry into this so-called endogenous pathway by a mechanism termed cross-presentation. This is known to be effective for class I–restricted cytotoxic T lymphocyte (CTL) cross-priming directed against a variety of exogenous tumor, viral, and minor transplantation antigens. The related effect of cross-tolerance can also effectively eliminate responses to selected self components. In both cases, this presentation appears to require the active involvement of a bone marrow–derived antigen presenting cell (APC). Here, we show that CTL induction by cross-priming with cell-associated ovalbumin requires the active involvement of CD4+ helper T cells. Importantly, this CD4+ population is only effective when both the helper and CTL determinants are recognized on the same APC. Moreover, we would argue that the cognitive nature of this event suggests that the CD4+ T cell actively modifies the APC, converting it into an effective stimulator for the successful priming of the CTL precursor.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

              A poorly immunogenic murine colon cancer was used to investigate mechanisms of antitumor immunity. Injection of tumor cells engineered by gene transfection to secrete IL-2 stimulated an MHC class I-restricted cytolytic T lymphocyte (CTL) response against the parental tumor. The tumor cells secreting IL-2 produced an antitumor response in vivo, even in the absence of CD4+ T cells. Animals immunized with the engineered cells were protected against subsequent challenge with the parental tumor cell line. Similar findings were demonstrated for other tumor types. Thus, provision of a helper lymphokine in a paracrine fashion induced a tumor-specific immune response involving activation of endogenous CTLs and other immune effector cells. These findings demonstrate that the failure of an effective antitumor immune response may be primarily due to a helper arm deficiency of the immune system rather than a paucity of tumor-specific cytotoxic effector cells. Furthermore, they outline a novel strategy for augmenting tumor immunity.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                15 December 1997
                : 186
                : 12
                : 2057-2062
                Affiliations
                From the [* ]Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Victoria 3050; and []The Department of Pathology and Immunology, Monash Medical School, Prahran 3181, Victoria, Australia
                Author notes

                Address correspondence to William R. Heath, Immunology Division, The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria 3050, Australia. Phone: 61-3-9345-2482; FAX: 61-3-9347-0852; E-Mail: heath@ 123456wehi.edu.au

                Article
                10.1084/jem.186.12.2057
                2199175
                9396776
                1ac158ce-3865-48be-bd38-4e6dbe49f7b9
                Copyright @ 1997
                History
                : 25 August 1997
                : 16 October 1997
                Categories
                Brief Definitive Report
                Brief Definitive Reports

                Medicine
                Medicine

                Comments

                Comment on this article